Recurrent Colon Carcinoma Terminated Phase 2 Trials for Capecitabine (DB01101)

Also known as: Carcinoma colon recurrent / Colon carcinoma recurrent / Colon cancer recurrent

IndicationStatusPhase
DBCOND0047445 (Recurrent Colon Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01729923A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal CancerTreatment